Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Lipopolysaccharides results in increased expression of CCL2; Lipopolysaccharides results in increased expression of CCL2 mRNA; Lipopolysaccharides results in increased expression of CCL2 protein
(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 4-hydroxyisoleucine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; 8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; [Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein; [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of CCL2 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA; [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein; AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]; AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; ATG5 protein affects the reaction [MJN110 affects the reaction [Lipopolysaccharides affects the secretion of CCL2 protein]]; bardoxolone methyl inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein]; Berberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of CCL2 protein]; bisphenol A promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA]; caffeic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Carbenoxolone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Cathelicidins inhibits the reaction [[Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; Chlorogenic Acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; CP 105696 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; DCB-SLE1 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Diethylhexyl Phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA]; dimemorfan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; Estradiol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of and results in increased secretion of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; FAAH protein affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; ferulic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Gallic Acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; GSR protein affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Hemin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]; IFNB1 protein affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; IL10 protein inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]; IL10 protein inhibits the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]]; IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; kaempferol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Latex promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Lipopolysaccharides promotes the reaction [RELA protein binds to CCL2 promoter]; Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein; luteolin 3'-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; luteolin-7-O-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; MGLL protein affects the reaction [Lipopolysaccharides affects the secretion of CCL2 protein]; MJN110 affects the reaction [Lipopolysaccharides affects the secretion of CCL2 protein]; Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Nicotine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; NR1H4 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; PARP1 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; PF 3845 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; PPARA affects the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; resolvin D2 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; RHBDF2 affects the reaction [4-hydroxyisoleucine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]; sodium arsenite promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; t-butyloxycarbonyl-methionyl-leucyl-phenylalanine inhibits the reaction [resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; terameprocol inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CCL2 promoter]]; terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; trans-sodium crocetinate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; triptolide promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA]; Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]; Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; ZFP36 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Zinc Oxide promotes the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]]
Lipopolysaccharides results in increased expression of CCL2; Lipopolysaccharides results in increased expression of CCL2 mRNA; Lipopolysaccharides results in increased expression of CCL2 protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; [Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein; ADM protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; CALCA protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; deferiprone inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein]; Deferoxamine inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein]; Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; tin protoporphyrin IX inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]
1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; 3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; [Cadmium Chloride co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA; [Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of CCL2 mRNA; [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL2 protein; [Zinc Sulfate co-treated with Disulfiram] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; Capsaicin promotes the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]; Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; Dinoprostone promotes the reaction [roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; Disulfiram inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; fluridone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; Gentamicins inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; gingerenone A inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; gingerenone A inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Lipopolysaccharides promotes the reaction [Histamine results in increased expression of CCL2 protein]; Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein; Naloxone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; SMIM20 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; SMIM20 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; Telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Zinc inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein]; Ziram inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]
